Showing results (141-150 of 625) with videos related to
Sort By:
Pageof 63
Organic & Biomolecular Chemistry|March 6, 2012
Highly efficient asymmetric Michael addition of aldehyde to nitroolefin using perhydroindolic acid as a chiral organocatalystLina Zhao, Jiefeng Shen, Delong Liu, et al.Journal of Hematology & Oncology|April 17, 2013
MEK and the inhibitors: from bench to bedsideAkintunde Akinleye, Muhammad Furqan, Nikhil Mukhi, et al.Journal of Hematology & Oncology|April 27, 2013
B-Raf and the inhibitors: from bench to bedsideTiangui Huang, Michael Karsy, Jian Zhuge, et al.Chemistry (Weinheim an Der Bergstrasse, Germany)|May 2, 2024
RuPHOX-Ru Catalyzed Asymmetric Cascade Hydrogenation of 3-Substituted Chromones for the Synthesis of Corresponding Chiral ChromanolsShaofeng Xu, Wenqi Xu, Siqi Dong, et al.Organic & Biomolecular Chemistry|February 2, 2011
Efficient palladium-catalyzed asymmetric allylic alkylation of ketones and aldehydesXiaohu Zhao, Delong Liu, Fang Xie, et al.Journal of the American Chemical Society|June 13, 2025
Rh-Catalyzed Asymmetric Hydrogenation of 3-Amino-4-alkyl/aryl Disubstituted MaleimidesJianxun Ye, Yicong Luo, Yunnan Xu, et al.Journal of Hematology & Oncology|April 18, 2015
Pass quantity, focus on qualityDelong Liu, Weijing Sun, Jingzhou Hou, et al.Journal of Hematology & Oncology|November 22, 2015
ABT-199 (venetoclax) and BCL-2 inhibitors in clinical developmentShundong Cang, Chaitanya Iragavarapu, John Savooji, et al.Experimental Hematology & Oncology|July 29, 2016
Complete remission after single agent blinatumomab in a patient with pre-B acute lymphoid leukemia relapsed and refractory to three prior regimens: hyperCVAD, high dose cytarabine mitoxantrone and CLAGKatherine Linder, Deepthi Gandhiraj, Madhura Hanmantgad, et al.Clinical Endocrinology|March 4, 2021
Factors influencing the reference interval of thyroid-stimulating hormone in healthy adults: A systematic review and meta-analysisDongyang Xing, Delong Liu, Ri Li, et al.Pageof 63